BridgeMD
New treatment option for Frail Elderly Patients
Official title A Multicenter Observational Study of an Integrated Traditional Chinese and Western Medicine Care Model in Post-Acute Treatment of Frail Elderly Patients
ClinicalTrials.gov ID: NCT07136935
What this study is testing
What is Traditional Chinese Medicine treatment?
Traditional Chinese Medicine treatment is an investigational medicine, given as an once-weekly pill taken by mouth, being studied as a potential treatment for frail elderly patients.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Exploring the Impact and Effectiveness of an Integrated Traditional Chinese and Western Medicine Treatment Model in Post-Acute Care for Frail Older Patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Elderly patients aged ≥75 years.
- A history of at least one of the following conditions: Parkinson's disease, chronic obstructive pulmonary disease (COPD), mild dementia, or chronic...
- Hospitalized due to an acute illness (length of hospital stay \>72 hours).
- Functional decline within one month after completion of treatment.
- Clinical Frailty Scale (CFS) score of 5-7 (indicating moderate or greater frailty, with retained rehabilitation potential).
You likely can't join if
- Medically unstable (requiring intensive medical interventions, diagnostic testing, or supplemental oxygen).
- Unable to cooperate with treatment or communication.
See the full eligibility criteria
- Elderly patients aged ≥75 years.
- A history of at least one of the following conditions: Parkinson's disease, chronic obstructive pulmonary disease (COPD), mild dementia, or chronic kidney disease at stage 3 or above.
- Hospitalized due to an acute illness (length of hospital stay \>72 hours).
- Functional decline within one month after completion of treatment.
- Clinical Frailty Scale (CFS) score of 5-7 (indicating moderate or greater frailty, with retained rehabilitation potential).
- Can answer clinical questionnaires and scales.
- Medically unstable (requiring intensive medical interventions, diagnostic testing, or supplemental oxygen).
- Unable to cooperate with treatment or communication.
The study team makes the final eligibility decision.
Where it's taking place
- Taichung, Taiwan
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taichung, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.